HEALTHCARE
Global Digital Pathology Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Digital Pathology Market, By Product (Device, Software, and Storage Systems), Deployment Mode (On-Premises and Cloud-Based), Type (Human Pathology and Veterinary Pathology), Application (Drug Discovery, Disease Diagnosis, and Training and Education), End Use (Pharmaceutical and Biotechnology Companies, Hospitals and Reference Laboratories, and Academic and Research Institutes), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
Market Dynamics
- Growing emphasis on remote consultations and telepathology
- Rising incidence of chronic diseases and cancer
- High initial costs
- Limited reimbursement and insurance coverage
- Development of advanced imaging technologies
- Investment in workflow optimization
- Cybersecurity threats
- Quality control and validation
SEGMENTATION
- Product
- Device
- Scanners
- Brightfield Scanners
- Others
- Slide Management System
- Software
- Integrated Software
- Standalone Software
- Information Management Software
- Image Analysis Software
- Storage Systems
- Deployment Mode
- On-Premises
- Cloud-Based
- Type
- Human Pathology
- Veterinary Pathology
- Application
- Drug Discovery
- Disease Diagnosis
- Training and Education
- End Use
- Pharmaceutical and Biotechnology Companies
- Hospitals and Reference Laboratories
- Academic and Research Institutes
KEY MARKET PLAYERS
- Danaher Corporation
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- PathAI
- Kanteron Systems
- Sectra AB
- Corista
- Huron Digital Pahology
- Aiforia
- F. Hoffmann-La Roche Ltd.
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Digital Pathology Market, by Product
- 3.2 Global Digital Pathology Market, by Deployment Mode
- 3.3 Global Digital Pathology Market, by Type
- 3.4 Global Digital Pathology Market, by Application
- 3.5 Global Digital Pathology Market, by End Use
- 3.6 Global Digital Pathology Market, by Geography
- 3.7 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Virtual slide viewing
- 5.1.2 Personalized medicine
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Growing emphasis on remote consultations and telepathology
- 5.2.2 Rising incidence of chronic diseases and cancer
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High initial costs
- 5.3.2 Limited reimbursement and insurance coverage
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Development of advanced imaging technologies
- 5.4.2 Investment in workflow optimization
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Cybersecurity threats
- 5.5.2 Quality control and validation
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT
- 6.1 Product Summary
- 6.2 Market Attractive Index
- 6.3 Global Digital Pathology Market, by Product (2019-2032)
- SECTION 7 - GLOBAL DIGITAL PATHOLOGY MARKET, BY DEPLOYMENT MODE
- 7.1 Deployment Mode Summary
- 7.2 Market Attractive Index
- 7.3 Global Digital Pathology Market, by Deployment Mode (2019-2032)
- SECTION 8 - GLOBAL DIGITAL PATHOLOGY MARKET, BY TYPE
- 8.1 Type Summary
- 8.2 Market Attractive Index
- 8.3 Global Digital Pathology Market, by Type (2019-2032)
- SECTION 9 - GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION
- 9.1 Application Summary
- 9.2 Market Attractive Index
- 9.3 Global Digital Pathology Market, by Application (2019-2032)
- SECTION 10 - GLOBAL DIGITAL PATHOLOGY MARKET, BY END USE
- 10.1 End Use Summary
- 10.2 Market Attractive Index
- 10.3 Global Digital Pathology Market, by End Use (2019-2032)
- SECTION 11 - GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY
- 11.1 Regional Summary
- 11.2 Market Attractive Index
- 11.3 Global Digital Pathology Market, by Geography (2019-2032)
- SECTION 12 - NORTH AMERICA DIGITAL PATHOLOGY MARKET
- 12.1 North America Summary
- 12.2 Market Attractive Index
- 12.3 North America Digital Pathology Market, by Product (2019-2032)
- 12.4 North America Digital Pathology Market, by Deployment Mode (2019-2032)
- 12.5 North America Digital Pathology Market, by Type (2019-2032)
- 12.6 North America Digital Pathology Market, by Application (2019-2032)
- 12.7 North America Digital Pathology Market, by End Use (2019-2032)
- 12.8 North America Digital Pathology Market, by Country (2019-2032)
- 12.8.1 U.S.
- 12.8.2 Canada
- 12.8.3 Mexico
- 12.8.4 Rest of North America
- SECTION 13 - EUROPE DIGITAL PATHOLOGY MARKET
- 13.1 Europe Summary
- 13.2 Market Attractive Index
- 13.3 Europe Digital Pathology Market, by Product (2019-2032)
- 13.4 Europe Digital Pathology Market, by Deployment Mode (2019-2032)
- 13.5 Europe Digital Pathology Market, by Type (2019-2032)
- 13.6 Europe Digital Pathology Market, by Application (2019-2032)
- 13.7 Europe Digital Pathology Market, by End Use (2019-2032)
- 13.8 Europe Digital Pathology Market, by Country (2019-2032)
- 13.8.1 Germany
- 13.8.2 U.K.
- 13.8.3 France
- 13.8.4 Italy
- 13.8.5 Spain
- 13.8.6 Russia
- 13.8.7 The Netherlands
- 13.8.8 Belgium
- 13.8.9 Turkey
- 13.8.10 Rest of Europe
- SECTION 14 - ASIA-PACIFIC DIGITAL PATHOLOGY MARKET
- 14.1 Asia-Pacific Summary
- 14.2 Market Attractive Index
- 14.3 Asia-Pacific Digital Pathology Market, by Product (2019-2032)
- 14.4 Asia-Pacific Digital Pathology Market, by Deployment Mode (2019-2032)
- 14.5 Asia-Pacific Digital Pathology Market, by Type (2019-2032)
- 14.6 Asia-Pacific Digital Pathology Market, by Application (2019-2032)
- 14.7 Asia-Pacific Digital Pathology Market, by End Use (2019-2032)
- 14.8 Asia-Pacific Digital Pathology Market, by Country (2019-2032)
- 14.8.1 China
- 14.8.2 India
- 14.8.3 Japan
- 14.8.4 South Korea
- 14.8.5 Singapore
- 14.8.6 Malaysia
- 14.8.7 Australia
- 14.8.8 Thailand
- 14.8.9 Philippines
- 14.8.10 Rest of Asia-Pacific
- SECTION 15 - SOUTH AMERICA DIGITAL PATHOLOGY MARKET
- 15.1 South America Summary
- 15.2 Market Attractive Index
- 15.3 South America Digital Pathology Market, by Product (2019-2032)
- 15.4 South America Digital Pathology Market, by Deployment Mode (2019-2032)
- 15.5 South America Digital Pathology Market, by Type (2019-2032)
- 15.6 South America Digital Pathology Market, by Application (2019-2032)
- 15.7 South America Digital Pathology Market, by End Use (2019-2032)
- 15.8 South America Digital Pathology Market, by Country (2019-2032)
- 15.8.1 Brazil
- 15.8.2 Argentina
- 15.8.3 Chile
- 15.8.4 Colombia
- 15.8.5 Rest of South America
- SECTION 16 - MIDDLE EAST AND AFRICA DIGITAL PATHOLOGY MARKET
- 16.1 Middle East and Africa Summary
- 16.2 Market Attractive Index
- 16.3 Middle East and Africa Digital Pathology Market, by Product (2019-2032)
- 16.4 Middle East and Africa Digital Pathology Market, by Deployment Mode (2019-2032)
- 16.5 Middle East and Africa Digital Pathology Market, by Type (2019-2032)
- 16.6 Middle East and Africa Digital Pathology Market, by Application (2019-2032)
- 16.7 Middle East and Africa Digital Pathology Market, by End Use (2019-2032)
- 16.8 Middle East and Africa Digital Pathology Market, by Country (2019-2032)
- 16.8.1 Kingdom of Saudi Arabia
- 16.8.2 South Africa
- 16.8.3 U.A.E.
- 16.8.4 Egypt
- 16.8.5 Rest of Middle East and Africa
- SECTION 17 - COMPANY SHARE ANALYSIS
- 17.1 Global Digital Pathology Market, Company Share Analysis
- 17.2 North America Digital Pathology Market, Company Share Analysis
- 17.3 Europe Digital Pathology Market, Company Share Analysis
- 17.4 Asia-Pacific Digital Pathology Market, Company Share Analysis
- SECTION 18 - COMPANY PROFILES
- 18.1 Danaher Corporation
- 18.1.1 Company Snapshot
- 18.1.2 Financial Overview
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Fujifilm Holdings Corporation
- 18.2.1 Company Snapshot
- 18.2.2 Financial Overview
- 18.2.3 Product Portfolio
- 18.2.4 Recent Developments
- 18.3 Koninklijke Philips N.V.
- 18.3.1 Company Snapshot
- 18.3.2 Financial Overview
- 18.3.3 Product Portfolio
- 18.3.4 Recent Developments
- 18.4 PathAI
- 18.4.1 Company Snapshot
- 18.4.2 Financial Overview
- 18.4.3 Product Portfolio
- 18.4.4 Recent Developments
- 18.5 Kanteron Systems
- 18.5.1 Company Snapshot
- 18.5.2 Financial Overview
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 Sectra AB
- 18.6.1 Company Snapshot
- 18.6.2 Financial Overview
- 18.6.3 Product Portfolio
- 18.6.4 Recent Developments
- 18.7 Corista
- 18.7.1 Company Snapshot
- 18.7.2 Financial Overview
- 18.7.3 Product Portfolio
- 18.7.4 Recent Developments
- 18.8 Huron Digital Pahology
- 18.8.1 Company Snapshot
- 18.8.2 Financial Overview
- 18.8.3 Product Portfolio
- 18.8.4 Recent Developments
- 18.9 Aiforia
- 18.9.1 Company Snapshot
- 18.9.2 Financial Overview
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 F. Hoffmann-La Roche Ltd.
- 18.10.1 Company Snapshot
- 18.10.2 Financial Overview
- 18.10.3 Product Portfolio
- 18.10.4 Recent Developments
- SECTION 19 - RELATED REPORTS
- SECTION 20 - DISCLAIMER
RESEARCH METHODOLOGY
RESEARCH AND DATA COLLECTION
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.